William Atkins
Analyst · Cowen and Company. Please proceed with your question
Thank you, Tom. We last provided you with guidance regarding Q2 on May 3. And in that guidance we called for revenue between $104 million and $108 million. Our gross margins are between 46% and 47% and operating expenses in a range of $52 million to $53 million, including approximately $2.4 million of Occam litigation expenses. Thus resulting in a net loss per share of between $0.09 and $0.05 or $0.04 to breakeven if Occam litigation expenses had been excluded. Relative to that guidance, our actual revenue for the quarter was $107.4 million and EPS was a loss of $0.04 per share including litigation expense or a profit of $0.02 per share excluding litigation expense with revenues at the upper end of guidance and the loss per share above the top end of guidance. Gross margin was 47.5% and operating expenses came in at $53million, which includes $2.8 million in litigation related expense. At the gross margin level, the largest drivers were favourable product and customer mix, partially offset by costs associated with the continued ramp of our previously announced turnkey network improvement project. Operating expenses included higher than expected legal expenses, and investments in R&D to support anticipated growth but nevertheless came in line with our guidance. A continuing focus on collections and working capital management resulted in positive operating cash flows of $0.1 million. Our aggregate balance of cash and marketable securities was flat sequentially at $64.2 million from $64.3 million in the prior quarter, primarily due to annual employee share purchase plan activity and better than expected operating cash flow, offset by capital expenditures of $1.6 million. Getting into a bit more of the detail, our $107.4 million in revenue for the quarter showed an increase of $8.3 million or 8.4% from last year’s second quarter level of $99.1 million. This is the second consecutive quarter when we have shown greater than 8% year-over-year growth, the first time in three years that we have demonstrated top line growth at these levels. At 7.7% of our Q2 revenues, international revenue was $8.3 million up just under $1 million in absolute dollars from its $7.5 million or 7.5% level in Q2 of last year. We had two 10% or greater customers this quarter. This marks the second consecutive quarter when we recorded more than one 10% or greater customer and it is the result of our focus on the increasing penetration of larger accounts. As I noted earlier, at 47.5% Q2 gross margin was above the upper end of our guidance range. This gross margin in Q2, 2016 was nevertheless down from Q2, 2015s 51% level, with this decrease driven in part by less favourable product and customer mix as well as the cost associated with the previously mentioned turnkey network improvement project. Q2 operating expenses at $53 million were up $5.7 million from the same quarter a year ago. With this year-over-year increase, primarily due to additions in headcounts, particularly in research and development and by litigation costs. We continue to invest in R&D to support our systems and software platforms to capitalize on the significant growth opportunities we are starting in 2016 and beyond. As we mentioned last quarter, in 2015 we launched the largest number of new systems and platforms in the company's history. So far in 2016, we are seeing solid momentum from these launches. Expenses related to the Occam litigation amounted to $2.8 million or $0.06 per share in Q2 2016 compared to $150,000 essentially $0.00 per share in Q2, 2015. This was higher than our guidance for $2.4 million as we incurred higher than estimated litigation expenses for trial and completion of the settlements agreement, which we submitted to the court for approval at the end of May. As previously disclosed, under the terms of the settlement, neither Calix nor any of its Directors or Officers contributes any payments of the settlement. Indeed, Calix will receive $4.5 million in cash as partial recovery of costs incurred, equivalent to $0.09 per share. This cost recovery partially offset the $9.5 million in out of pocket Occam litigation expenses incurred to date. We expect to recognize this $4.5 million reimbursement to Calix in Q3, based on our expectation of court approval of the settlement agreement in Q3. At this stage of the year, it’s worth pausing to review how Calix performed over the first half of 2016 relative to the same period last year. First half 2016 revenues increased by $15.6 million to $205.8 million, or up 8.2% from last year’s $119.2 million level. This has been our strongest first half growth since 2013. Gross margins came in at 47.8% for the first half versus 2015s first half number of 50.1%. Operating expenses increased by $9.2 million to $104.7 million versus 2015s first half level of $95.5 million. After deducting Occam litigation expenses of $6.2 million in 2016 and $1.9 million in 2015, the first half operating expense figure would have increased by $4.9 million to $98.5 million from last year’s $93.6 million level. First half 2016 earnings per share were a loss of $0.13 versus last year’s first half EPS of breakeven or $0.00 per share. Excluding Occam litigation expenses, first half 2016 earnings per share were breakeven or $0.00 per share versus last year’s first half EPS of $0.03 per share. Turning now to the balance sheet. As noted earlier, we ended the quarter with total cash and marketable securities of $64.2 million, flat from Q1, and a decrease of $35.3 million from last year’s Q2 level. The primary driver in the year-over-year decrease in cash was our $40 million share repurchase program, which was completed during Q1, 2016. Receivables DSOs were healthy 36 days, down 2 days compared to the previous quarter and down 1 day from the 37 days in Q2, 2015. The overall quality of our receivables and our collections performance remains strong. Inventory levels decreased to $40.8 million in Q2, down from Q1's $41.1 million level and essentially flat from $40.7 million in Q2, 2015. With the revenues rising at a strong pace, both year-on-year and sequentially we are pleased by our teams performance and managing working capital. Inventory turns increased to 4.5 times in Q2 from 3.9 times in Q1 and also increased from Q2, 2015 4 times. Now let me turn to guidance for the third quarter of 2016. We expect revenues to be in a range of between $115 million and $119 million, with the midpoint of $117 [ph] million, up 4% from the quarterly record $112 million level of Q3, 2015. At the mid-point of guidance, nine months 2016 revenues would increase by 6.7% year-over-year. This will be the first year since 2013 that our first nine months revenues are expected to grow at this strong a pace relative to the prior year period. We are guiding gross margin to a 45.5% to 46.5% range from Q3, down from last year’s Q3 level of 49.3%. With this decline, relative to Q3, 2015 largely driven by the continued ramp of turnkey network improvement projects as well as by our expectation of slightly less favourable product and customer mix relative to Q3, 2015. As we’ve mentioned on previous calls, these key projects are strategic for both the company and for our customers and we are accelerating activity in Q3 and Q4.This will put some near term pressure on our gross margins as these activities accelerate. In terms of operating expenses we expect to recognize the recovery and the settlement of the Occam litigation, which remains subject to court approval in Q3. Based on the accounting treatment, the settlement will be reflected as an offset to operating expenses as it is a partial recovery of non-reimbursed litigation expenses incurred through Q2. This entry will be reflected in both our GAAP and non-GAAP results in the amount of $4.5 million or $0.09 on a per share basis. Therefore we expect operating expenses including the Occam litigation settlement to be in the range of $48.5 million to $49.5 million. Excluding the settlement proceeds, we expect operating expenses to be in the range of $53 million to $54 million, up from last year’s Q3 level of $46.6 million with the increase reflecting incremental hiring costs to support our growth initiatives. Based on 49.1 million diluted shares, the expectations that I’ve just finished taking you through results in a guidance range for Q3 of a net profit of $0.08 to $0.12 on a per share basis or a loss of $0.01 to a positive profit of $0.03 per share excluding litigation settlement proceeds. We also anticipate negative operating cash flow in Q3. At this point, let me hand the call over to Carl. Carl?